Current applications and efficacy of scleral contact lenses — a retrospective study
Identifieur interne : 004780 ( Ncbi/Merge ); précédent : 004779; suivant : 004781Current applications and efficacy of scleral contact lenses — a retrospective study
Auteurs : Boris Severinsky [Israël] ; Michel Millodot [Royaume-Uni]Source :
- Journal of Optometry [ 1888-4296 ] ; 2010.
Abstract
To evaluate the indications and efficacy of high gas permeable scleral contact lenses (GP-SCL).
A total database of 97 consecutive patients (140 eyes) fitted with GP-SCL between January 2003 and December 2008, was retrospectively analyzed to determine the benefits of fitting scleral lenses. All lenses were fitted by preformed technique and were non-fenestrated. Patients included keratoconus – 88 eyes (63 %); corneal irregularities after penetrating keratoplasty – 39 eyes (28 %); various ocular surface disorders: Stevens-Johnson syndrome (SJS), graft versus host disease (GVHD) and exposure keratopathy – 6 eyes (4 %); post refractive surgery keratoectasia – 4 eyes (3 %), and high refractive error – 3 eyes (2 %).
Mean follow up was 27.5 months (range 1–71), mean wearing time in successful wearers group was 12.2 hours per day (range 10–16), mean wearing time in group of wearers who dropped out using GP-SCL, was 5.8 hours (range 3–8). Keratoconus patients achieved median best corrected visual acuity (BCVA) of 20/32, 84 % of patients achieved BCVA of 20/40 or more. The post keratoplasty group achieved median BCVA of 20/25, 92 % of patients achieved BCVA of 20/40 or better. In the other groups, median BCVA was as follows: ocular surface disorders – 20/50, keratoectasia – 20/30, high refractive error – 20/32. Positive fluid-venting was highly associated with successful GP-SCL wearing. Twenty patients (21 %) failed to wear GP-SCL.
GP-SCL's expand the management of various corneal abnormalities. The main indication for GP-SCL is optical correction of an irregular corneal surface, especially keratoconus and corneal transplant.
Url:
DOI: 10.1016/S1888-4296(10)70022-4
PubMed: NONE
PubMed Central: 3974288
Links toward previous steps (curation, corpus...)
- to stream Pmc, to step Corpus: 001466
- to stream Pmc, to step Curation: 001466
- to stream Pmc, to step Checkpoint: 001F25
Links to Exploration step
PMC:3974288Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Current applications and efficacy of scleral contact lenses — a retrospective study</title><author><name sortKey="Severinsky, Boris" sort="Severinsky, Boris" uniqKey="Severinsky B" first="Boris" last="Severinsky">Boris Severinsky</name><affiliation wicri:level="1"><nlm:aff id="aff0005">Ophthalmology Dept., Contact Lens Clinic, Hadassah University Hospital, Jerusalem, Israel</nlm:aff><country xml:lang="fr">Israël</country><wicri:regionArea>Ophthalmology Dept., Contact Lens Clinic, Hadassah University Hospital, Jerusalem</wicri:regionArea><wicri:noRegion>Jerusalem</wicri:noRegion></affiliation></author><author><name sortKey="Millodot, Michel" sort="Millodot, Michel" uniqKey="Millodot M" first="Michel" last="Millodot">Michel Millodot</name><affiliation wicri:level="1"><nlm:aff id="aff0010">School of Optometry and Vision Science, Cardiff University, UK</nlm:aff><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>School of Optometry and Vision Science, Cardiff University</wicri:regionArea><wicri:noRegion>Cardiff University</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmc">3974288</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3974288</idno><idno type="RBID">PMC:3974288</idno><idno type="doi">10.1016/S1888-4296(10)70022-4</idno><idno type="pmid">NONE</idno><date when="2010">2010</date><idno type="wicri:Area/Pmc/Corpus">001466</idno><idno type="wicri:Area/Pmc/Curation">001466</idno><idno type="wicri:Area/Pmc/Checkpoint">001F25</idno><idno type="wicri:Area/Ncbi/Merge">004780</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Current applications and efficacy of scleral contact lenses — a retrospective study</title><author><name sortKey="Severinsky, Boris" sort="Severinsky, Boris" uniqKey="Severinsky B" first="Boris" last="Severinsky">Boris Severinsky</name><affiliation wicri:level="1"><nlm:aff id="aff0005">Ophthalmology Dept., Contact Lens Clinic, Hadassah University Hospital, Jerusalem, Israel</nlm:aff><country xml:lang="fr">Israël</country><wicri:regionArea>Ophthalmology Dept., Contact Lens Clinic, Hadassah University Hospital, Jerusalem</wicri:regionArea><wicri:noRegion>Jerusalem</wicri:noRegion></affiliation></author><author><name sortKey="Millodot, Michel" sort="Millodot, Michel" uniqKey="Millodot M" first="Michel" last="Millodot">Michel Millodot</name><affiliation wicri:level="1"><nlm:aff id="aff0010">School of Optometry and Vision Science, Cardiff University, UK</nlm:aff><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>School of Optometry and Vision Science, Cardiff University</wicri:regionArea><wicri:noRegion>Cardiff University</wicri:noRegion></affiliation></author></analytic><series><title level="j">Journal of Optometry</title><idno type="ISSN">1888-4296</idno><idno type="eISSN">1989-1342</idno><imprint><date when="2010">2010</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><sec><title>Purpose</title><p>To evaluate the indications and efficacy of high gas permeable scleral contact lenses (GP-SCL).</p></sec><sec><title>Methods</title><p>A total database of 97 consecutive patients (140 eyes) fitted with GP-SCL between January 2003 and December 2008, was retrospectively analyzed to determine the benefits of fitting scleral lenses. All lenses were fitted by preformed technique and were non-fenestrated. Patients included keratoconus – 88 eyes (63 %); corneal irregularities after penetrating keratoplasty – 39 eyes (28 %); various ocular surface disorders: Stevens-Johnson syndrome (SJS), graft versus host disease (GVHD) and exposure keratopathy – 6 eyes (4 %); post refractive surgery keratoectasia – 4 eyes (3 %), and high refractive error – 3 eyes (2 %).</p></sec><sec><title>Results</title><p>Mean follow up was 27.5 months (range 1–71), mean wearing time in successful wearers group was 12.2 hours per day (range 10–16), mean wearing time in group of wearers who dropped out using GP-SCL, was 5.8 hours (range 3–8). Keratoconus patients achieved median best corrected visual acuity (BCVA) of 20/32, 84 % of patients achieved BCVA of 20/40 or more. The post keratoplasty group achieved median BCVA of 20/25, 92 % of patients achieved BCVA of 20/40 or better. In the other groups, median BCVA was as follows: ocular surface disorders – 20/50, keratoectasia – 20/30, high refractive error – 20/32. Positive fluid-venting was highly associated with successful GP-SCL wearing. Twenty patients (21 %) failed to wear GP-SCL.</p></sec><sec><title>Conclusions</title><p>GP-SCL's expand the management of various corneal abnormalities. The main indication for GP-SCL is optical correction of an irregular corneal surface, especially keratoconus and corneal transplant.</p></sec></div></front></TEI><pmc article-type="research-article"><pmc-comment>The publisher of this article does not allow downloading of the full text in XML form.</pmc-comment>
<front><journal-meta><journal-id journal-id-type="nlm-ta">J Optom</journal-id><journal-title-group><journal-title>Journal of Optometry</journal-title></journal-title-group><issn pub-type="ppub">1888-4296</issn><issn pub-type="epub">1989-1342</issn></journal-meta><article-meta><article-id pub-id-type="pmc">3974288</article-id><article-id pub-id-type="publisher-id">S1888-4296(10)70022-4</article-id><article-id pub-id-type="doi">10.1016/S1888-4296(10)70022-4</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Current applications and efficacy of scleral contact lenses — a retrospective study</article-title><trans-title-group xml:lang="es"><trans-title>Aplicaciones actuales y eficacia de las lentes de contacto esclerales: un estudio retrospectivo</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name><surname>Severinsky</surname><given-names>Boris</given-names></name><email>severinkiy@yahoo.com</email><xref rid="aff0005" ref-type="aff">a</xref><xref rid="cor0005" ref-type="corresp">⁎</xref></contrib><contrib contrib-type="author"><name><surname>Millodot</surname><given-names>Michel</given-names></name><xref rid="aff0010" ref-type="aff">b</xref></contrib></contrib-group><aff id="aff0005"><label>a</label>Ophthalmology Dept., Contact Lens Clinic, Hadassah University Hospital, Jerusalem, Israel</aff><aff id="aff0010"><label>b</label>School of Optometry and Vision Science, Cardiff University, UK</aff><author-notes><corresp id="cor0005"><label>⁎</label>Corresponding author: Ophthalmology Dept., Contact Lens Clinic, Hadassah University Hospital, Jerusalem, Israel. <email>severinkiy@yahoo.com</email></corresp></author-notes><pub-date pub-type="pmc-release"><day>7</day><month>12</month><year>2010</year></pub-date><pmc-comment> PMC Release delay is 0 months and 0 days and was based on .</pmc-comment>
<pub-date pub-type="epub"><day>7</day><month>12</month><year>2010</year></pub-date><pub-date pub-type="ppub"><month>7</month><year>2010</year></pub-date><volume>3</volume><issue>3</issue><fpage>158</fpage><lpage>163</lpage><history><date date-type="received"><day>27</day><month>3</month><year>2010</year></date><date date-type="accepted"><day>13</day><month>8</month><year>2010</year></date></history><permissions><copyright-statement>© 2010 Spanish Council of Optometry</copyright-statement><copyright-year>2010</copyright-year></permissions><abstract><sec><title>Purpose</title><p>To evaluate the indications and efficacy of high gas permeable scleral contact lenses (GP-SCL).</p></sec><sec><title>Methods</title><p>A total database of 97 consecutive patients (140 eyes) fitted with GP-SCL between January 2003 and December 2008, was retrospectively analyzed to determine the benefits of fitting scleral lenses. All lenses were fitted by preformed technique and were non-fenestrated. Patients included keratoconus – 88 eyes (63 %); corneal irregularities after penetrating keratoplasty – 39 eyes (28 %); various ocular surface disorders: Stevens-Johnson syndrome (SJS), graft versus host disease (GVHD) and exposure keratopathy – 6 eyes (4 %); post refractive surgery keratoectasia – 4 eyes (3 %), and high refractive error – 3 eyes (2 %).</p></sec><sec><title>Results</title><p>Mean follow up was 27.5 months (range 1–71), mean wearing time in successful wearers group was 12.2 hours per day (range 10–16), mean wearing time in group of wearers who dropped out using GP-SCL, was 5.8 hours (range 3–8). Keratoconus patients achieved median best corrected visual acuity (BCVA) of 20/32, 84 % of patients achieved BCVA of 20/40 or more. The post keratoplasty group achieved median BCVA of 20/25, 92 % of patients achieved BCVA of 20/40 or better. In the other groups, median BCVA was as follows: ocular surface disorders – 20/50, keratoectasia – 20/30, high refractive error – 20/32. Positive fluid-venting was highly associated with successful GP-SCL wearing. Twenty patients (21 %) failed to wear GP-SCL.</p></sec><sec><title>Conclusions</title><p>GP-SCL's expand the management of various corneal abnormalities. The main indication for GP-SCL is optical correction of an irregular corneal surface, especially keratoconus and corneal transplant.</p></sec></abstract><trans-abstract xml:lang="es"><title>Resumen</title><sec><title>Objetivos</title><p>Evaluar las indicaciones y eficacia de las lentes de contacto esclerales de alta permeabilidad al gas (LCE-PG).</p></sec><sec><title>Métodos</title><p>Se analizó de forma retrospectiva una base de datos con un total de 97 pacientes consecutivos (140 ojos) que fueron prescritos LCE-PG entre enero 2003 y diciembre 2008, para determinar los beneficios de llevar lentes esclerales. Todas las lentes fueron adaptadas mediante técnica preformada y no estaban fenestras. Entre los pacientes, había 88 (63 %) ojos queratoconos; 39 ojos (28 %) con irregularidades corneales después de queratoplastia penetrante; diversos trastornos superficiales oculares: síndrome de Stevens-Johnson (SSJ), enfermedad injerto contra huésped (GVHD, en inglés) y 6 ojos (4 %) con queratopatía por exposición; 4 ojos (3 %) con queratectasia tras cirugía refractiva, y 3 ojos (2 %) con elevado defecto refractivo.</p></sec><sec><title>Resultados</title><p>El seguimiento medio fue de 27,5 meses (intervalo 1–71), el tiempo medio de uso en el grupo que se adaptó con éxito a las LCE-PG fue de 12,2 horas por día (intervalo 10–16), la media de uso en el grupo que las abandonó fue de 5,8 horas (intervalo 3–8). Los pacientes con queratocono lograron una mediana de mejor agudeza visual corregida (BCVA, en inglés) de 20/32, el 84 % de los pacientes lograron una BCVA de 20/40 o superior. El grupo de posqueratoplastia logró una BCVA mediana de 20/25, el 92 % de los pacientes lograron una BCVA de 20/40 o superior. En los otros grupos, la BCVA mediana fue la siguiente: trastornos oculares superficiales: 20/50; queratectasia: 20/30, defecto refractario alto: 20/32. La ventilación de fluido positiva estaba altamente asociada con una adaptación exitosa a las LCE-PG. Veinte pacientes (21 %) no lograron usar las LCE-PG.</p></sec><sec><title>Conclusiones</title><p>Las LCE-PG amplían las posibilidades de tratamiento de diversas anormalidades corneales. La indicación principal para las LCE-PG es la corrección óptica de una superficie corneal irregular, especialmente en queratocono y trasplante corneal.</p></sec></trans-abstract><kwd-group><title>Keywords</title><kwd>Scleral lenses</kwd><kwd>Gas permeable scleral lenses</kwd><kwd>Therapeutic lenses</kwd><kwd>Visual acuity</kwd></kwd-group><kwd-group xml:lang="es"><title>Palabras clave</title><kwd>Lentes de contacto esclerales</kwd><kwd>Lentes esclerales permeables al gas</kwd><kwd>Lentes terapéuticas</kwd><kwd>Agudeza visual</kwd></kwd-group></article-meta></front></pmc><affiliations><list><country><li>Israël</li><li>Royaume-Uni</li></country></list><tree><country name="Israël"><noRegion><name sortKey="Severinsky, Boris" sort="Severinsky, Boris" uniqKey="Severinsky B" first="Boris" last="Severinsky">Boris Severinsky</name></noRegion></country><country name="Royaume-Uni"><noRegion><name sortKey="Millodot, Michel" sort="Millodot, Michel" uniqKey="Millodot M" first="Michel" last="Millodot">Michel Millodot</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Ticri/CIDE/explor/HapticV1/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004780 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 004780 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Ticri/CIDE
|area= HapticV1
|flux= Ncbi
|étape= Merge
|type= RBID
|clé= PMC:3974288
|texte= Current applications and efficacy of scleral contact lenses — a retrospective study
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i -Sk "pubmed:NONE" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd \
| NlmPubMed2Wicri -a HapticV1
| This area was generated with Dilib version V0.6.23. |  |